Whole-body MRI for staging prostate cancer: a narrative review.

Andrew M Fang Justin R GreggCurtis PettawayJingfei MaJanio SzklarukTharakeswara K BathalaDevaki Shilpa S SurasiBrian F Chapin

Published in: BJU international (2024)

The diagnostic capabilities of WBMRI exceed that of conventional imaging of CT and BS in detecting metastatic disease in patients with HRPCa. However, WBMRI does not perform as well as PSMA PET/CT. Further study on cost comparisons between WBMRI and PSMA PET/CT are needed, as well as evaluations of combined PSMA PET/MRI are needed.

Keyphrases

pet ct
contrast enhanced
prostate cancer
positron emission tomography
magnetic resonance imaging
computed tomography
diffusion weighted imaging
small cell lung cancer
squamous cell carcinoma
radical prostatectomy
high resolution
image quality
mass spectrometry
photodynamic therapy